Rapid Micro Biosystems (RPID) Free Cash Flow Growth (3y) (2023 - 2026)
Rapid Micro Biosystems (RPID) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 77.20% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | -29.89% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | -0.27% |
| 10 | Rapid Micro Biosystems | 89.96 Mn | 80.52 Mn | 371,000.00 | 4.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.76% |
| Dec 31, 2025 | 23.33% |
| Sep 30, 2025 | 22.18% |
| Jun 30, 2025 | 10.10% |
| Mar 31, 2025 | 21.17% |
| Dec 31, 2024 | 7.01% |
| Sep 30, 2024 | 24.51% |
| Jun 30, 2024 | 5.69% |
| Mar 31, 2024 | -11.85% |
| Dec 31, 2023 | -18.94% |
| Sep 30, 2023 | -4.69% |